At levels of therapeutic anticoagulation, VKAs (vitamin K antagonists) typically cause only mild prolongation (or do not prolong) the activated partial thromboplastin time (aPTT), and they do not prolong the anti-factor Xa activity level, a test typically used to measure the effect of heparin or direct oral factor Xa inhibitors
I was not able to find a mechanism for why VKAs might not prolong aPTT, but there is evidence to suggest that it can prolong aPTT, especially at higher doses and has an additive effect when administered with heparin.
As your question alluded to, factor VII has the shortest half-life (4-6 hours), which makes the PT/INR coagulation tests most sensitive for testing warfarin's anticoagulation effect. Higher levels of warfarin might prolong aPTT, but is not as reliable for monitoring warfarin's effect.
At levels of therapeutic anticoagulation, VKAs (vitamin K antagonists) typically cause only mild prolongation (or do not prolong) the activated partial thromboplastin time (aPTT), and they do not prolong the anti-factor Xa activity level, a test typically used to measure the effect of heparin or direct oral factor Xa inhibitors
I was not able to find a mechanism for why VKAs might not prolong aPTT, but there is evidence to suggest that it can prolong aPTT, especially at higher doses and has an additive effect when administered with heparin.
As your question alluded to, factor VII has the shortest half-life (4-6 hours), which makes the PT/INR coagulation tests most sensitive for testing warfarin's anticoagulation effect. Higher levels of warfarin might prolong aPTT, but is not as reliable for monitoring warfarin's effect.
I figured it might be a matter of PT just being a more sensitive test for warfarin than aPTT and not warfarin having no effect on aPTT at all. Issue is my professors take the latter to be true which added to the confusion.More
According to UpToDate:
I was not able to find a mechanism for why VKAs might not prolong aPTT, but there is evidence to suggest that it can prolong aPTT, especially at higher doses and has an additive effect when administered with heparin.
As your question alluded to, factor VII has the shortest half-life (4-6 hours), which makes the PT/INR coagulation tests most sensitive for testing warfarin's anticoagulation effect. Higher levels of warfarin might prolong aPTT, but is not as reliable for monitoring warfarin's effect.
According to UpToDate:
I was not able to find a mechanism for why VKAs might not prolong aPTT, but there is evidence to suggest that it can prolong aPTT, especially at higher doses and has an additive effect when administered with heparin.
As your question alluded to, factor VII has the shortest half-life (4-6 hours), which makes the PT/INR coagulation tests most sensitive for testing warfarin's anticoagulation effect. Higher levels of warfarin might prolong aPTT, but is not as reliable for monitoring warfarin's effect.
More
VOTE
VOTE